Molecules 2012, 17(3), 3524-3538; doi:10.3390/molecules17033524
Review

Terpenoids as Potential Anti-Alzheimer’s Disease Therapeutics

1 and 2,* email
Received: 7 December 2011; in revised form: 12 March 2012 / Accepted: 16 March 2012 / Published: 19 March 2012
(This article belongs to the Special Issue Terpenoids)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Alzheimer’s disease (AD) is one of the most well-known neurodegenerative diseases and explains 50–60% of dementia in patients. The prevalence rate of AD is positively correlated with age and AD affects ≥ 40% of those over 85 years old. The major AD therapeutics available on the market are acetylcholinesterase inhibitors, such as tacrine and donepezil. New therapeutic agents that can block the disease-inducing mechanisms are essential. Diverse efforts have been made to discover anti-AD agents from natural sources. In this review article, we describe some representative terpenoids such as ginsenosides, gingkolides, and canabinoids as potential anti-AD agents. These compounds exhibit promising in vitro and in vivo biological activities, but are still waiting clinical trials. Additionally, we also discuss some terpenoids including cornel iridoid glycoside, oleanolic acid, tenuifolin, cryptotanshinone, and ursolic acid, which are under investigation for their in vitro and in vivo animal studies.
Keywords: Alzheimer’s disease; therapeutics; terpenoids
PDF Full-text Download PDF Full-Text [646 KB, uploaded 18 June 2014 19:45 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Yoo, K.-Y.; Park, S.-Y. Terpenoids as Potential Anti-Alzheimer’s Disease Therapeutics. Molecules 2012, 17, 3524-3538.

AMA Style

Yoo K-Y, Park S-Y. Terpenoids as Potential Anti-Alzheimer’s Disease Therapeutics. Molecules. 2012; 17(3):3524-3538.

Chicago/Turabian Style

Yoo, Ki-Yeol; Park, So-Young. 2012. "Terpenoids as Potential Anti-Alzheimer’s Disease Therapeutics." Molecules 17, no. 3: 3524-3538.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert